Riskpilot← Back to searchSign inGet full accessSVINGEN LEGESENTER AS
ASActiveOrg 982911125Nymosvingen 6, 2609 LillehammerGeneral medical practice activities · NACE 8621Est. 20018 employees
Revenue 2025
NOK 4,5M
-7% vs 2024
EBITDA margin
1.2%
-49% vs 2024
Equity ratio
-1.8%
Financial strength
Net profit 2025
NOK 20K
-69% vs 2024
| Revenue | NOK 4,5M | -7% |
| EBITDA | NOK 54K | -49% |
| Net profit | NOK 20K | -69% |
| Total assets | NOK 705K | +23% |
| Equity | NOK -13K | +61% |
| Employees | 8 | — |
Legal name
SVINGEN LEGESENTER AS
Org number
982911125
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
1. februar 2001
Share capital
NOK 250 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Ivareta felles støttefunksjoner for aksjonærenes fastlegepraksiser.
Address
Nymosvingen 6, 2609 Lillehammer
Phone
+4761057900
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 609 | 4 244 | 4 456 | 4 814 | 4 480 |
| Staff expenses | −1 834 | −1 733 | −1 948 | −2 254 | −2 014 |
| EBITDA | −444 | 25 | 44 | 106 | 54 |
| Depreciation & amort. | −36 | −25 | −44 | −41 | −41 |
| EBIT | −480 | −0 | 0 | 64 | 13 |
| Net financials | −0 | 0 | −0 | −0 | 7 |
| Profit before tax | −480 | −0 | −0 | 64 | 20 |
| Tax | −106 | −0 | 124 | −0 | −0 |
| Net profit | −374 | 0 | −124 | 64 | 20 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 053 | 951 | 589 | 575 | 705 |
| Equity | 27 | 27 | −97 | −33 | −13 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 026 | 924 | 686 | 608 | 718 |
| Total debt | 1 026 | 924 | 686 | 608 | 718 |
EBITDA margin
1.2%
This company
15.8%
Market median
-92% vs market
20212025
Equity ratio
-1.8%
This company
38.2%
Market median
-105% vs market
20212025
Return on equity
1998500.0%
This company
18.4%
Market median
+10861313% vs market
20212025
Net profit margin
0.4%
This company
8.1%
Market median
-95% vs market
20212025
Asset turnover
6.35×
This company
1.12×
Market median
+467% vs market
20212025
Debt / equity
57.24×
This company
0.62×
Market median
-9132% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Chairman | 2018 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 | |
| Company | 20% | 20% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SVINGEN LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Frode Oosterling | Chairman | 0 companies |
| Ingeborg Eskerud | Board of Directors | 0 companies |
| Julie Wendelbo | Board of Directors | 0 companies |